These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12382210)

  • 21. Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals.
    Brauch RA; Adnan El-Masri M; Parker JC; El-Mallakh RS
    J Affect Disord; 2006 Mar; 91(1):87-90. PubMed ID: 16469390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuropathology of primary mood disorder.
    Harrison PJ
    Brain; 2002 Jul; 125(Pt 7):1428-49. PubMed ID: 12076995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurons and glial cells in bipolar disorder: A systematic review of postmortem brain studies of cell number and size.
    Gigase FAJ; Snijders GJLJ; Boks MP; de Witte LD
    Neurosci Biobehav Rev; 2019 Aug; 103():150-162. PubMed ID: 31163205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder.
    Bezchlibnyk YB; Sun X; Wang JF; MacQueen GM; McEwen BS; Young LT
    J Psychiatry Neurosci; 2007 May; 32(3):203-10. PubMed ID: 17476367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphological changes of the brain in mood disorders.
    Wilczyńska K; Simonienko K; Konarzewska B; Szajda SD; Waszkiewicz N
    Psychiatr Pol; 2018 Oct; 52(5):797-805. PubMed ID: 30584814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia.
    Cotter D; Hudson L; Landau S
    Bipolar Disord; 2005 Aug; 7(4):358-69. PubMed ID: 16026489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.
    Rajkowska G; Miguel-Hidalgo JJ; Wei J; Dilley G; Pittman SD; Meltzer HY; Overholser JC; Roth BL; Stockmeier CA
    Biol Psychiatry; 1999 May; 45(9):1085-98. PubMed ID: 10331101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell density and cortical thickness in Heschl's gyrus in schizophrenia, major depression and bipolar disorder.
    Cotter D; Mackay D; Frangou S; Hudson L; Landau S
    Br J Psychiatry; 2004 Sep; 185():258-9. PubMed ID: 15339832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.
    Zarate CA; Du J; Quiroz J; Gray NA; Denicoff KD; Singh J; Charney DS; Manji HK
    Ann N Y Acad Sci; 2003 Nov; 1003():273-91. PubMed ID: 14684452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphometric analysis of neuronal and glial cell pathology in the caudate nucleus in late-life depression.
    Khundakar A; Morris C; Oakley A; Thomas AJ
    Am J Geriatr Psychiatry; 2011 Feb; 19(2):132-41. PubMed ID: 20808096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.
    Carlson PJ; Singh JB; Zarate CA; Drevets WC; Manji HK
    NeuroRx; 2006 Jan; 3(1):22-41. PubMed ID: 16490411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gliogenesis and glial pathology in depression.
    Rajkowska G; Miguel-Hidalgo JJ
    CNS Neurol Disord Drug Targets; 2007 Jun; 6(3):219-33. PubMed ID: 17511618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low glial numbers in the amygdala in major depressive disorder.
    Bowley MP; Drevets WC; Ongür D; Price JL
    Biol Psychiatry; 2002 Sep; 52(5):404-12. PubMed ID: 12242056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on regional brain volume differences associated with mood disorders.
    Campbell S; MacQueen G
    Curr Opin Psychiatry; 2006 Jan; 19(1):25-33. PubMed ID: 16612175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circumscribed numerical deficit of dorsal raphe neurons in mood disorders.
    Baumann B; Bielau H; Krell D; Agelink MW; Diekmann S; Wurthmann C; Trübner K; Bernstein HG; Danos P; Bogerts B
    Psychol Med; 2002 Jan; 32(1):93-103. PubMed ID: 11883733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?
    Jeon WJ; Dean B; Scarr E; Gibbons A
    Curr Neuropharmacol; 2015; 13(6):739-49. PubMed ID: 26630954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the treatment of affective disorders.
    Joyce PR; Paykel ES
    Aust N Z J Psychiatry; 2006 May; 40(5):379-80. PubMed ID: 16683961
    [No Abstract]   [Full Text] [Related]  

  • 38. Volume deficits of subcortical nuclei in mood disorders A postmortem study.
    Bielau H; Trübner K; Krell D; Agelink MW; Bernstein HG; Stauch R; Mawrin C; Danos P; Gerhard L; Bogerts B; Baumann B
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):401-12. PubMed ID: 16080015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum markers support disease-specific glial pathology in major depression.
    Schroeter ML; Abdul-Khaliq H; Krebs M; Diefenbacher A; Blasig IE
    J Affect Disord; 2008 Dec; 111(2-3):271-80. PubMed ID: 18430474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered glial plasticity in animal models for mood disorders.
    Czéh B; Fuchs E; Flügge G
    Curr Drug Targets; 2013 Oct; 14(11):1249-61. PubMed ID: 23597041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.